Literature DB >> 11276203

A point mutation in CD28 distinguishes proliferative signals from survival signals.

K Okkenhaug1, L Wu, K M Garza, J La Rose, W Khoo, B Odermatt, T W Mak, P S Ohashi, R Rottapel.   

Abstract

Upon interaction with its ligand, B7, CD28 becomes phosphorylated on tyrosines. One tyrosine in particular (Y170 in mouse CD28, Y173 in human CD28) has received much attention. This is because it permits CD28 to recruit SH2-containing signaling molecules, including phosphoinositide 3 kinase, Grb2 and Gads. Using mice we employed a transgenic approach to express a tyrosine-->phenylalanine mutant form of CD28 that uncouples these SH2-mediated interactions from CD28. The CD28 mutant is unable to up-regulate expression of the prosurvival protein Bcl-xL, rendering the T cells more susceptible to radiation-induced death. Nonetheless, this mutated form of CD28 still prevents the induction of anergy and promotes T cell proliferation, interleukin 2 secretion and B cell help. Thus, we describe a single point mutation within the CD28 cytoplasmic domain that uncouples signals required for proliferation and survival.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11276203     DOI: 10.1038/86327

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  65 in total

Review 1.  Activation and inhibition of lymphocytes by costimulation.

Authors:  Kenneth A Frauwirth; Craig B Thompson
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

2.  Specificity and affinity motifs for Grb2 SH2-ligand interactions.

Authors:  Helmut W H G Kessels; Alister C Ward; Ton N M Schumacher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-25       Impact factor: 11.205

Review 3.  Genetic analysis of CD28 signaling.

Authors:  Tiffani A Greene; Virginia Smith Shapiro
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

4.  Azathioprine: old drug, new actions.

Authors:  Jonathan S Maltzman; Gary A Koretzky
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 5.  Memory T-cell trafficking: new directions for busy commuters.

Authors:  Federica M Marelli-Berg; Hongmei Fu; Fabrizio Vianello; Koji Tokoyoda; Alf Hamann
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

Review 6.  An enigmatic tail of CD28 signaling.

Authors:  Jonathan S Boomer; Jonathan M Green
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-06-09       Impact factor: 10.005

7.  Syk mediates BCR- and CD40-signaling integration during B cell activation.

Authors:  Haiyan Ying; Zhenping Li; Lifen Yang; Jian Zhang
Journal:  Immunobiology       Date:  2010-10-07       Impact factor: 3.144

8.  A highly recurrent novel missense mutation in CD28 among angioimmunoblastic T-cell lymphoma patients.

Authors:  Seung Ho Lee; Ji Sun Kim; Jaesang Kim; Seok Jin Kim; Won Seog Kim; Sanghyuk Lee; Young Hyeh Ko; Hae Yong Yoo
Journal:  Haematologica       Date:  2015-09-24       Impact factor: 9.941

9.  Regulated costimulation in the thymus is critical for T cell development: dysregulated CD28 costimulation can bypass the pre-TCR checkpoint.

Authors:  Joy A Williams; Karen S Hathcock; David Klug; Yohsuke Harada; Baishakhi Choudhury; James P Allison; Ryo Abe; Richard J Hodes
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

Review 10.  mTOR at the crossroads of T cell proliferation and tolerance.

Authors:  Anna Mondino; Daniel L Mueller
Journal:  Semin Immunol       Date:  2007-03-23       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.